BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoingPublic.de - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.goingpublic.de
X-WR-CALDESC:Veranstaltungen für GoingPublic.de
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250505
DTEND;VALUE=DATE:20250508
DTSTAMP:20260412T110013
CREATED:20241205T134245Z
LAST-MODIFIED:20241205T134245Z
UID:148787-1746435600-1746608399@www.goingpublic.de
SUMMARY:Swiss Biotech Day
DESCRIPTION:Experience the Swiss Biotech Day\, a premier biotechnology conference\, and join us in 2025 for an unparalleled gathering of more than 2\,500 professionals from the global life sciences community. Explore the latest advancements in R&D\, manufacturing\, data management\, artificial intelligence\, and innovative financing. \n\n\n\n\n\n\n© Swiss Biotech Association\n\n\n\n\n\n\n\n\n\n\nWhat awaits you:\n\n\nExtensive networking: Start with the welcome reception on the eve before the conference to warm up to two days of networking.\nGlobal Village: Connect with international biotech clusters to strengthen your ties with the Swiss biotech hub\, by fostering cross-border investments\, public-private partnerships\, collaborations and exchange of talent.\nExhibition excellence: Discover over 100 exhibitors alongside the poster exhibition by Swiss biotech innovators.\nInspirational talks and awards: Attend our thematic pitching sessions\, panel discussions\, and celebrate industry achievements with the Swiss Biotech Success Stories Awards.\nExclusive insights: Get the first look at the Swiss Biotech Report 2025\, outlining the most important trends\, factors and sources of biotech innovation.\nEfficient partnering: Maximize your visit with pre-scheduled one-to-one meetings\, tailored to foster meaningful business relationships.
URL:https://www.goingpublic.de/event/swiss-biotech-day-2/
LOCATION:Congress Center Basel\, Messeplatz 21\, Basel\, 4058\, Switzerland
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/jpeg:https://www.goingpublic.de/wp-content/uploads/2024/12/SBD-Banner_GoingPublic-Kalender.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20250508T163000
DTEND;TZID=Europe/Berlin:20250508T203000
DTSTAMP:20260412T110013
CREATED:20250313T132418Z
LAST-MODIFIED:20250313T132418Z
UID:151361-1746721800-1746736200@www.goingpublic.de
SUMMARY:Netzwerktreffen Life Sciences im IZB
DESCRIPTION:  \nDas 5. Netzwerktreffen der Plattform Life Sciences findet am 8.Mai 2025 statt. Das letztjährige Netzwerktreffen der Plattform\, bot den Teilnehmern nicht nur eine Fülle an Wissen und kurzweilige Diskussionen\, sondern auch eine Gelegenheit zum Entspannen und Reflektieren. Im Faculty Club im Innovations- und Gründerzentrum Biotechnologie (IZB) in Martinsried lauschten die Gäste inspirierenden Vorträgen über die Zukunft der Biotechnologie\, die ein Gefühl der Zuversicht und Aufbruchsstimmung vermittelten. \n  \nAgenda: \n16:30 – 17:00 Uhr: Registrierung /Networking\n17:00 – 17:15 Uhr: Begrüßung \n17:15 – 18:20 Uhr: Impulsvorträge & Diskussion \n18.20 Uhr: Drinks und gute Gespräche auf der Terrasse des Seven and More (bei schlechtem Wetter innen)\n20.30 Uhr: Offizielles Ende \nZur Anmeldung klicken Sie hier.  \n 
URL:https://www.goingpublic.de/event/netzwerktreffen-life-sciences-im-izb/
LOCATION:Innovations- und Gründerzentrum Biotechnologie (IZB)\, Innovations- und Gründerzentrum Biotechnologie (IZB) Am Klopferspitz 19\, Planegg\, Bayern\, 82152\, Germany
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/png:https://www.goingpublic.de/wp-content/uploads/2025/03/Header-MailingNetzwerktreffen2025.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250512
DTEND;VALUE=DATE:20250516
DTSTAMP:20260412T110013
CREATED:20250313T131944Z
LAST-MODIFIED:20250313T131944Z
UID:151357-1747040400-1747299599@www.goingpublic.de
SUMMARY:Frühjahrskonferenz 2025
DESCRIPTION:Vom 12. bis 14. Mai 2025  findet die jährliche  Frühjahrskonferenz  in Frankfurt statt. Über 100 Börsennotierte Unternehmen aus dem In- und Ausland präsentieren ihre aktuellen Geschäftszahlen und Ausblicke für das folgende Geschäftsjahr vor ausgesuchten Investoren\, Analysten\, Finanzjournalisten und Akteuren des Kapitalmarkts. \nWeitere Informationen zur Veranstaltung\, Anmeldung und zum Programm finden Sie hier.
URL:https://www.goingpublic.de/event/fruehjahrskonferenz-2025/
LOCATION:Flemings Selection Hotel Frankfurt-City
CATEGORIES:Medienpartner
ATTACH;FMTTYPE=image/jpeg:https://www.goingpublic.de/wp-content/uploads/2024/01/Equity-Forum-Fruehjahrskonferenz.jpg
ORGANIZER;CN="EF Equity Forum UG":MAILTO:info (at) equityforum.de
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250514
DTEND;VALUE=DATE:20250517
DTSTAMP:20260412T110013
CREATED:20241205T113731Z
LAST-MODIFIED:20241205T113731Z
UID:148771-1747213200-1747385999@www.goingpublic.de
SUMMARY:Bionnale
DESCRIPTION:BIONNALE is the largest networking event for life sciences and healthcare industries in the German capital region. \nRepresentatives from academia and industry attend the annual life sciences event in Berlin to identify\, engage and start strategic relationships. The networking character is one strength of BIONNALE with more than 1500 attendees from over 45 countries in 2023. Be part of BIONNALE 2025 and use informative talks and new contacts for your business. We look forward to meeting you online or in Berlin! \nWhat to expect? \n\nKeynote\nSessions \nMatchmaking opportunities (onsite and online) with an organized and web-based matchmaking system\nCooperation & Venture Track including tech-based company and academic presentations\nOnsite industry exhibition to present your products and services\nBIONNALE Speed Lecture Award and Get Together\n\nWhen? \nWednesday and Thursday\, 14-15 May 2025 \nWhere? \nBIONNALE 2025 will be an on-site (14 May 2025\, Berlin) and virtual (15 May 2025) event. \nLocation: \nLudwig Erhard Haus\, Fasanenstraße 85 – 10623 Berlin\, Germany \nWho will be attending? \nCompanies and research institutions from the region and beyond looking for co-development or joint research opportunities – Startups with new ideas and innovative approaches – Investors on the corporate\, institutional and VC sides and other stakeholders. \nThe participation in the event is free of charge.\n 
URL:https://www.goingpublic.de/event/bionnale/
LOCATION:Ludwig Erhard Haus\, Fasanenstraße.85\, Berlin\, Germany
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/webp:https://www.goingpublic.de/wp-content/uploads/2024/12/Berlin-Partner-Wandkalender_105x60mm.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250514
DTEND;VALUE=DATE:20250518
DTSTAMP:20260412T110013
CREATED:20250108T145234Z
LAST-MODIFIED:20250108T145234Z
UID:150344-1747213200-1747472399@www.goingpublic.de
SUMMARY:Handelsblatt Jahrestagung Restrukturierung 2025
DESCRIPTION:In einer Zeit\, in der Unsicherheit die wirtschaftliche Landschaft prägt\, sind Unternehmen mehr denn je gefordert\, strategische Entscheidungen zu treffen. Mit dem Fokus „fix\, sell\, close – Wette auf die Zukunft“ diskutieren wir\, wie Unternehmen auf die volatilen Märkte reagieren können: \nWie können Unternehmen sich optimieren?\nWann ist es angebracht sich von Unternehmensteilen zu trennen?\nWann müssen Unternehmen in die Insolvenz gehen?\nWelche Finanzierungen stehen zur Verfügung? Oft entscheidet die Anpassungsfähigkeit eines Unternehmens über den Erfolg. \nNutzen Sie die Möglichkeit\, sich mit Experten aus Beratungen\, Unternehmen und dem Finanzbereich in Zeiten von Investitionsunsicherheiten auszutauschen. Erörtern Sie bewährte Strategien und gewinnen Sie neue Perspektiven. Stellen Sie gemeinsam die Weichen für die Zukunft und erfahren Sie\, wie Sie Ihre Wette auf die Zukunft gewinnberingend gestalten können.
URL:https://www.goingpublic.de/event/handelsblatt-jahrestagung-restrukturierung-2025/
LOCATION:Hilton Frankfur\, Hochstraße 4\, Frankfurt am Main\, 60313\, Deutschland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20250515T073000
DTEND;TZID=Europe/Berlin:20250516T172000
DTSTAMP:20260412T110013
CREATED:20250425T094134Z
LAST-MODIFIED:20250425T094134Z
UID:152264-1747294200-1747416000@www.goingpublic.de
SUMMARY:ICPO Forum for Theranostics in Precision Oncology –  Shape the future of Theranostics with us on May 15 & 16\, 2025 in Munich\, Germany!
DESCRIPTION:Listen to talks and panels from 40 international renowned experts about the global evolution of Theranostics\, advances in education and centers accreditation\, radiopharmaceuticals game changers\, and implementation of AI as a backbone for Theranostics centers worldwide. \nJoin the symposium about critical unmet needs in female cancer treatments and the patient session with insights on international patient journeys. Don’t miss the final round table\, „What synergies are needed in the field of theranostics?“ moderated by the pioneer of Theranostics\, Prof. Dr. Richard P. Baum. \nMore than 200 attendees from Europe\, India\, China\, the Middle East\, the United States\, Canada and other countries around the world are expected\, while more than 20 industry sponsors are supporting the event\, including Novartis\, Telix\, ITM\, Siemens Healthineers\, GE Healthcare\, Mediso\, SOFIE and others. \nHave a look on the event trailer: ICPO Forum for Theranostics in Precision Oncology on May 15 & 16\, 2025 in Munich\, Germany \nAnd register here: https://www.icpo-forum.org/scientific-programme-FORUM.html \nWe are looking forward to your participation!
URL:https://www.goingpublic.de/event/icpo-forum-for-theranostics-in-precision-oncology-shape-the-future-of-theranostics-with-us-on-may-15-16-2025-in-munich-germany/
LOCATION:Science Congress Center Munich\, Walther-von-Dyck-Straße 10\, Garching\, 85748\, Deutschland
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/jpeg:https://www.goingpublic.de/wp-content/uploads/2025/04/2025_03_31-ICPO-Forum.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20250515T120000
DTEND;TZID=Europe/Berlin:20250515T183000
DTSTAMP:20260412T110013
CREATED:20241127T155931Z
LAST-MODIFIED:20250108T145559Z
UID:148555-1747310400-1747333800@www.goingpublic.de
SUMMARY:19. Private Equity-Konferenz NRW
DESCRIPTION:Thema: Wachstumsfinanzierung
URL:https://www.goingpublic.de/event/19-private-equity-konferenz-nrw/
LOCATION:Rheinterrasse Düsseldorf\, Joseph-Beuys-Ufer 33\, Düsseldorf\, 40479\, Deutschland
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/jpeg:https://www.goingpublic.de/wp-content/uploads/2024/11/NRWB-Life-Sciences-Kalender-2025-281124.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250519
DTEND;VALUE=DATE:20250522
DTSTAMP:20260412T110013
CREATED:20240614T131331Z
LAST-MODIFIED:20241217T135250Z
UID:145460-1747645200-1747817999@www.goingpublic.de
SUMMARY:Family Day 2025
DESCRIPTION:Der HTGF Family Day ist für Sie eine ideale Plattform\, um Ideen auszutauschen\, Inspiration zu schöpfen und von einzigartigen Investitions- und Kooperationsmöglichkeiten zu profitieren.\nHier kommen Unternehmer\, Investoren und Innovatoren zusammen\, um die Zukunft mitzugestalten! \n\n\n\n\n\nOffene Börsen\n\n\nGewinnen Sie wertvolle Erkenntnisse für Investoren\, Gründer und Unternehmer\, indem Sie Erfolge\, Herausforderungen und Misserfolge offen diskutieren. \n\n\n\n\n1:1-Meetings\n\n\nProfitieren Sie von hochfokussierten Networking-Möglichkeiten\, die durch unser Matchmaking-Tool unterstützt werden. \n\n\n\n\n\n\n\n\nLernen Sie aus den Erfahrungen anderer\n\n\nHolen Sie sich in Keynotes\, Vorträgen und Podiumsdiskussionen neue Perspektiven von Vordenkern und lernen Sie aus den Erfahrungen anderer erfolgreicher Unternehmer. \n\n\n\n\nHTGF Portfolio\nInsights\n\n\nHören Sie aus erster Hand die Geschichten der HTGF-Portfoliogründer über ihre Start-ups und erleben Sie Pitch-Sessions zu den wichtigsten Technologiebereichen.
URL:https://www.goingpublic.de/event/family-day-2025/
LOCATION:STATION Berlin\, Luckenwalder Str. 4-6\, Berlin\, 10963\, Deutschland
CATEGORIES:Life Sciences
ATTACH;FMTTYPE=image/png:https://www.goingpublic.de/wp-content/uploads/2024/06/FD25-Logo-Schwarz.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250521
DTEND;VALUE=DATE:20250523
DTSTAMP:20260412T110013
CREATED:20250313T131833Z
LAST-MODIFIED:20250313T131833Z
UID:151356-1747818000-1747904399@www.goingpublic.de
SUMMARY:15. IFF – International Investment Forum
DESCRIPTION:The International Investment Forum (IIF) is an online platform providing insights into various industries such as mining\, energy\, and biotechnology. Top executives from around the world present their companies and trends\, allowing for efficient and environmentally friendly participation without the need to travel. \nRegistration is already open. \n 
URL:https://www.goingpublic.de/event/15-iff-international-investment-forum/
LOCATION:Digital
CATEGORIES:Going Public,Medienpartner
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250531
DTEND;VALUE=DATE:20250602
DTSTAMP:20260412T110013
CREATED:20241205T090822Z
LAST-MODIFIED:20241217T162806Z
UID:148744-1748682000-1748768399@www.goingpublic.de
SUMMARY:10th Annual Oncology Innovation Forum
DESCRIPTION:We are pleased to announce that the 10th Annual Oncology Innovation Forum (Sachs_OIF) will take place at the Waldorf Astoria Chicago Hotel on the 31st of May 2024\, at the beginning of the ASCO meeting. The Virtual Week will follow from the 12th to 14th of June. \nThe 10th Annual OIF is an established networking opportunity for senior biotech executives to meet Pharma Licensing teams and financial and corporate investors and their advisers. Meetings take place alongside a stimulating program focusing on the latest trends in pharma-biotech dealmaking\, the latest innovation in IO targets and modalities. There is also an ASCO forecast panel with industry analysts sharing their views on what to expect. This will be available on demand for the virtual audience the week after ASCO. Additionally\, there will be pre-arranged in-person and virtual meetings\, live and on-demand company showcases\, and a reception. \nThe event brings together leaders from cancer research institutes\, patient advocacy groups\, pharma\, biotech\, and Wall Street\, to facilitate partnering\, funding and investment. We anticipate around 250 delegates and 20+ company presentations by established and emerging companies with part of the audience participating virtually. This will include a limited number of live presentations taking place in dedicated presentation tracks\, alongside virtual company showcases\, which will be available on demand. Recorded sessions will also be added on demand on the events portal during the virtual week. \nThe programme will consist of: \nFriday\, 31st of May (Central Daylight Time (CDT) zone): \n\nBioPharma Dealmakers Roundtable\nNew Endpoints for Early-Stage Oncology Companies Panel\nInvesting in NextGen ADCs Panel\nAdvanced Immunotherapies Panel: Cell Therapies & Cancer Vaccines\nNew Methods of Therapeutic Delivery for Oncology Panel\nNew Hubs for Innovation Panel\nASCO Forecast Discussion\n\nNetworking Reception – 31st of May\nIn-Person Meetings – 31st of May\nVirtual Meetings via Online Meeting System – 12th – 14th of June (Eastern Daylight Time (EDT) zone) \n\n\n\nConfirmed Speakers & Chairs Include: \n\nAndreas Pahl\, CEO\, Heidelberg Pharma AG\nBenjamin Burnett\, Equity Research Analyst\, Stifel\nBrad Loncar\, Founder\, BiotechTV\nColette Lipp\, Director\, Global BD Oncology & Immuno-Oncology\, Merck KGaA\, Darmstadt\, Germany\nDavid G. Benathan\, VP\, BD&L Partnering Head Oncology\, Novartis AG\nDeborah Rathjen\, Managing Director & CEO\, Carina Biotech Limited\nDevang Bhuva\, SVP\, Corporate Development & Alliance Management\, Gilead Sciences\, Inc.\nEvonne Sepsis\, Managing Director\, ESC Advisors\nGregor Fachinger\, VP\, Head of Oncology & Immuno-Oncology Business Development\, Merck KGaA\, Darmstadt\, Germany\nJacob Plieth\, Senior Reporter\, ApexOnco\nJames Barlow\, President & CEO\, ImmunoGenesis\, Inc.\nJay Olson\, Managing Director & Senior Analyst\, Oppenheimer & Co. Inc.\nJean-Pierre Latere\, CEO\, EsoBiotec\nJeffrey Bockman\, EVP Expert Advisor\, Oncology\, Lumanity Head\, Oncology Center of Excellence\, Lumanity\nJoel Sandler\, Associate Partner\, Ipsos Healthcare Advisory Service\nJohn DeYoung\, VP\, Worldwide Business Development\, Pfizer\, Inc.\nJohn Flavin\, Founder & CEO\, Portal Innovations\, LLC\nJun Xu\, Executive Director – Therapy Acceleration Program Lead\, The Leukemia & Lymphoma Society\nKaveri Pohlman\, Director\, Biotechnology Equity Research\, BTIG\, LLC\nMargarita Chavez\, Venture Partner\, Wellington Partners\nMatthew Price\, Co-Founder\, EVP & Chief Operating Officer\, Promontory Therapeutics Inc.\nMaurits Geerlings\, President & CEO\, NanoCell Therapeutics\, Inc.\nMax Nisen\, Equity Research Analyst\, Pharma & Biotech\, Bloomberg Intelligence\nMichael Kingston\, Managing Director & Head of North America Life Sciences\, Lazard Ltd.\nMichael Rice\, Expert Advisor\, SVP\, Cell & Gene Therapy\, Lumanity\nMichael Salgaller\, Supervisor Specialist\, National Institutes of Health (NIH)\nMichal Preminger\, Regional Head\, Johnson & Johnson Innovation East North America\, Johnson & Johnson Innovation LLC\nNadim Ahmed\, President & CEO\, Cullinan Therapeutics\, Inc.\nNicole Fay\, Director of Pharmacology\, Nutcracker Therapeutics\, Inc.\nNiels Emmerich\, VP\, Search & Evaluation & Global Alliances\, AbbVie\, Inc.\nNiranjan Sardesai\, Founder\, President & CEO\, Geneos Therapeutics\, Inc.\nOmari Wise\, Vice President Business Development\, Amgen\, Inc.\nPaul Rennert\, CEO\, Aleta Biotherapeutics\nPete DeMuth\, Chief Scientific Officer\, Elicio Therapeutics\, Inc.\nPeter Sandor\, EVP Head of Corporate Strategy\, Astellas Pharma\, Inc.\nPolly Brown\, VP\, Head of Business Development\, Oncology R&D\, AstraZeneca\nRaven Lin\, Co-Founder & CEO\, Pilatus Biosciences SA\nSath Nirmalananthan\, Chief Financial Officer\, Scancell Holdings PLC\nSharon Chan\, VP JLABS Asia Pacific\, Johnson & Johnson\nSusie Harborth\, Chief Business Officer\, Breakthrough Properties\nUciane Scarlett\, Principal Venture Capitalist\, MPM BioImpact\nUpendra Marathi\, CEO\, 7 Hills Pharma Inc.\nVivek Abraham\, Director\, Oncology Search & Evaluation\, AbbVie\, Inc.\nXavier Avat\, Chief Business Officer\, Moffitt Cancer Center\nYuval Cohen\, CEO\, Corbus Pharmaceuticals Holdings\, Inc.\n\n\n\n\n\n\n\n\nPARTICIPATION OPTIONS INCLUDE:\n\nComplimentary passes are provided for qualified institutional (buy/sell-side)\, private equity and venture investors. The number of passes is limited\, and priority is given to regular participants\, however the organiser has the discretion to reject registrations. Other participants may consider purchasing access\, which includes in-person or virtual participation\, with different options to showcase your company.\n\nNETWORKING OPPORTUNITIES:\n\nThe Online Meeting System will open on the 17th of May for uploading profiles and sending meeting invites. The in-person meetings will be taking place on the 31st of May\, while virtual meetings will take place on the 12th – 14th of June. For the virtual meetings\, the system will allow you to have a secure audio/video call\, as well as an option to present slides using a screen share function and we will have a dedicated room for in-person meetings.\n\nPRESENTING OPPORTUNITIES:\n\n\nGain additional exposure to high-level decision makers by presenting at the forum\, which offers excellent opportunities to showcase your company’s investment and partnering offering. This typically includes technology and financial highlights. This adds to the news flow from the forum and generates greater interest in meetings from other delegates. \nPresentations are a popular and useful way to gain additional exposure with potential investors and pharma partners\, which make up over half the audience. We are pleased to announce that once again we will have 20-minute and 10-minute presentations taking place in-person at the dedicated presenting tracks. Here you will be able to showcase your company in front of investors attending the physical event. The recording will be added to your company’s profile during the virtual week\, which will be available on demand for registered participants until the event portal closes. \nFor those who cannot present in-person\, but are still interested to showcase their company\, there is an option to purchase either a 20 or 10 minute presentation\, which will be pre-recorded in advance and available to all registered attendees on the events portal. Start-up companies may also purchase a 5-minute pre-recorded showcase instead. \nThe Sachs Team can assist with the pre-recording of the presentation\, or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System \n\n\nConfirmed Presenters Include:
URL:https://www.goingpublic.de/event/10th-annual-oncology-innovation-forum/
LOCATION:Waldorf Astoria Hotel Chicago\, 11 E Walton\, Chicago\, 60611\, United States
CATEGORIES:Life Sciences,Medienpartner
ATTACH;FMTTYPE=image/jpeg:https://www.goingpublic.de/wp-content/uploads/2016/03/Sachs-Logo.jpg
END:VEVENT
END:VCALENDAR